Anti-Müllerian hormone (AMH) helps estimate the pool of small follicles that may respond to ovarian stimulation, but it does not measure egg quality or determine whether you will become pregnant. A low, normal, or high result must be interpreted with age, menstrual history, ultrasound, other tests, and the reason for testing.

What AMH measures

AMH is produced by small follicles. In assisted reproduction, it can help anticipate a lower or higher response to stimulation medicines and support safety planning. That is different from predicting natural pregnancy in a particular month. Results also vary with the assay, laboratory, hormonal contraception, and ovarian conditions.

AMH is not a fertility clock

Age remains one of the strongest reproductive factors because it relates to egg chromosomal quality. AMH describes one dimension of ovarian reserve, not fertility as a whole. In Steiner’s study, reserve biomarkers did not simply identify which older women would experience infertility [2].

Low, normal, or high results

Low AMH can occur in someone who still ovulates and does not prove infertility. High AMH can occur with polycystic ovary syndrome and does not guarantee regular ovulation; it may also signal a higher stimulation response. One number does not justify supplements, delaying care, or starting treatment. Nelson’s cohort links AMH levels to time to pregnancy, but cannot predict an individual outcome [1].

AMH and trying naturally

For someone trying without treatment, the test is not an individual countdown. Harris and colleagues studied ovarian reserve markers and future fertility, but did not turn AMH into a yes-or-no fertility test [3]. Cycles, ovulation, tubes, semen, age, and intercourse timing also matter.

When evaluation helps

  • Ask why the test was ordered and what decision it may change.
  • Bring the result, age, cycles, surgeries, treatments, and family history to the appointment.
  • Seek assessment for absent or very irregular periods, endometriosis, ovarian surgery, or time trying without pregnancy beyond the recommended interval.
  • Do not compare your number directly with another person or an internet range.

How Levvi helps

Levvi records period start, flow, symptoms, cervical mucus, basal temperature, and tests in trying-to-conceive mode. For example, bring three months of records to compare cycle regularity and ovulation signs with the AMH result. The app does not measure AMH, ovarian reserve, or egg quality and does not interpret laboratory tests.

What should you ask about the result?

Ask which assay the laboratory used, whether hormonal contraception could have affected the result, and what decision the test is meant to guide. A result may help plan stimulation, but it does not need repeating without a reason. If it does not fit the cycle history or ultrasound, the team can revisit the context rather than choose the most alarming interpretation.

What the papers cannot answer

AMH studies are observational or reviews of different studies, so they cannot predict one person’s reproductive future. They do not turn the marker into a menopause diagnosis, report the chromosomal quality of each egg, or measure tubal patency or male factors. This limitation is essential when interpreting associations without overclaiming.

Frequently asked questions

  • Is high AMH always good? No; it may reflect many follicles or PCOS and must be related to ovulation.
  • Does low AMH mean menopause? No. Ovulation may still occur and other factors need assessment.
  • Should I freeze eggs based only on AMH? No. Age, plans, health, and counseling matter.
  • Does Levvi read my report? No; bring the official result to the team and use the app for the timeline.

Practical example: record the collection date, cycle start, and symptoms in Levvi, while keeping the AMH number in the official report. At the visit, compare it with age, follicle count, menstrual pattern, and treatment goal. This prevents one marker from being used outside the question it was ordered to answer.

How to apply the evidence to your case

A cohort study follows people over time and may observe fecundability; a review combines studies with different methods. Neither design turns AMH into an individual pregnancy test. If the test was ordered before assisted reproduction, the practical question may be stimulation response; during natural attempts, the discussion should include age, ovulation, tubes, and semen. Seek care for absent periods, persistent pelvic pain, ovarian surgery, or trying beyond the recommended interval.

Example: two people with similar AMH may have different ages, cycles, and ultrasounds and receive different advice. Record cycles and symptoms in Levvi, while leaving decisions to the team that knows the full results.

How to read the references

Reference [1] is Nelson’s cohort linking AMH with time to pregnancy; [3] is Harris’s study of ovarian reserve markers and future fertility. Both are informative, but neither turns AMH into an individual prediction. Assessment should combine age, cycles, and other factors.

Conclusion and clinical limits

AMH is one piece of the puzzle. It can support stimulation planning in assisted reproduction, but it does not independently determine pregnancy chances or label someone fertile or infertile. Responsible interpretation combines age, history, examination, and other data with a qualified clinical team.